1. Effect of astragaloside IV and the role of nuclear receptor RXRα in human peritoneal mesothelial cells in high glucose‑based peritoneal dialysis fluids
   Weiwei Zhu et al, 2019, Molecular Medicine Reports CrossRef
2. IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis
   Vanessa Marchant et al, 2020, Biomolecules CrossRef
3. PPARγ and Its Agonists in Chronic Kidney Disease
   Yuhua Ma et al, 2020, International Journal of Nephrology CrossRef
4. Effects of sitagliptin on peritoneal membrane: The potential role of mesothelial cell tight junction proteins
   Chor ho Jo et al, 2023, Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis CrossRef
5. PPAR-γ agonist rosiglitazone ameliorates peritoneal deterioration in peritoneal dialysis rats with LPS-induced peritonitis through up-regulation of AQP-1 and ZO-1
   Yunfang Zhang et al, 2018, Bioscience Reports CrossRef
6. Protective effects of lutein against vancomycin-induced acute renal injury in mice via upregulation of peroxisome proliferator-activated receptor gamma/nuclear factor erythroid 2-related factor 2 and inhibition nuclear factor-kappaB/caspase 3
   Promise M. Emeka et al, 2021, The Korean Journal of Physiology & Pharmacology CrossRef